List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Osteoporosis - Overview
Osteoporosis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Osteoporosis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Osteoporosis - Companies Involved in Therapeutics Development
Osteoporosis - Drug Profiles
Osteoporosis - Dormant Projects
Osteoporosis - Discontinued Products
Osteoporosis - Product Development Milestones
Featured News & Press Releases
Aug 10, 2022: Rani Therapeutics announces positive topline results from phase 1 study of RT-102 in osteoporosis
Aug 08, 2022: Rani Therapeutics enters into $45 million loan agreement to support ongoing Ramipril platform advancement and clinical pipeline development
Jul 20, 2022: Alvotech initiates a pharmacokinetic study for AVT03, a proposed biosimilar for Prolia and Xgeva
Jul 20, 2022: Henlius Denosumab Biosimilar HLX14 received clinical trial approval in Australia for the phase 3 MRCT
Jul 18, 2022: Entera Bio announces execution of key regulatory milestones for EB613, the first oral anabolic drug proposed for the treatment of Osteoporosis; Miranda Toledano assumes CEO Position
Jun 17, 2022: Voluntary announcement - First patient has been dosed in an international multicentre phase 3 clinical trial for a biosimilar of denosumab HLX14 (recombinant anti-RANKL human monoclonal antibody injection) for the treatment of postmenopausal osteoporosis in women with high fracture risks in Mainland China
Jun 08, 2022: Radius Health expands Non-US market footprint for TYMLOS
Jun 01, 2022: Radius Health update on Abaloparatide Transdermal System
May 03, 2022: Rani Therapeutics' RaniPill capsule named winner in the Health category of fast company's 2022 World Changing Ideas Awards
Apr 29, 2022: Transcenta doses first subject in Phase I osteoporosis drug trial in China
Apr 01, 2022: Thousands of people set to benefit from first new treatment for osteoporosis for over a decade
Mar 23, 2022: Rani Therapeutics announces initiation of phase 1 study of RT-102 oral PTH for osteoporosis
Mar 10, 2022: Amgen keeps dominating Korea's osteoporosis treatment market
Mar 01, 2022: Radius Health files sNDA for TYMLOS in Men with osteoporosis
Feb 17, 2022: Entera Bio to present at Aegis Virtual Conference on February 23rd
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Osteoporosis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Osteoporosis - Dormant Projects, 2022
Osteoporosis - Discontinued Products, 2022

List of Figures
Number of Products under Development for Osteoporosis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Top 10 Targets, 2022
Number of Products by Stage and Top 10 Targets, 2022
Number of Products by Top 10 Mechanism of Actions, 2022
Number of Products by Stage and Top 10 Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

Companies Mentioned
• Abiogen Pharma SpA
• Ablynx NV
• Abreos Biosciences Inc
• Aclaris Therapeutics Inc
• Addpharma Inc
• Aerami Therapeutics Inc
• Affilogic SAS
• AgeX Therapeutics Inc
• Airsea (Taizhou) Pharmaceutical Ltd
• AlphaMab Co Ltd
• Alvotech SA
• Amgen Inc
• Amogen Pharma Pvt Ltd
• Angitia Biopharmaceuticals
• Aryogen Pharmed Co
• Aveta Biomics Inc
• Bainan Biotech ApS
• Beijing Kangleweishi Biotechnology Co Ltd
• Beijing Northland Biotech Co Ltd
• Beryl Therapeutics Inc
• Better Life Pharmaceuticals Inc
• Biocon Ltd
• Bone Biologics Corp
• Cellatoz Therapeutics Inc
• Celltrion Inc
• China NT Pharma Group Co Ltd
• ChoDang Pharm Co Ltd
• Citragen Pharmaceuticals Inc
• CK Regeon Inc
• Clayton Biotechnologies Inc
• Clonz Biotech Pvt Ltd
• Corium Inc
• CSPC Pharmaceutical Group Ltd
• Curexsys GmbH
• Daewoong Pharmaceutical Co Ltd
• Dongkook Pharmaceutical Co Ltd
• Eden Biologics Inc
• Eli Lilly and Co
• Endoceutics Inc
• Enesi Pharma Ltd
• Entera Bio Ltd
• Enteris BioPharma Inc
• Enzene Biosciences Ltd
• Enzo Biochem Inc
• Epygen Biotech Pvt Ltd
• Evgen Pharma Plc
• Fresenius Kabi SwissBioSim GmbH
• Galapagos NV
• Gbiologics Inc
• Gedeon Richter Plc
• Genor BioPharma Co Ltd
• Genu Pharma Co Ltd
• GlycoNex Inc
• GPN Therapeutics Inc
• Haoma Medica Ltd
• Helixmith Co Ltd
• Histide AG
• HNB Therapeutics LLC
• Hualan Biological Engineering Inc
• Huons Global Co Ltd
• IMGENEX India Pvt Ltd
• Immunwork Inc
• InnoPharmaScreen Inc
• Intas Pharmaceuticals Ltd
• Ipsen SA
• Jiangsu Hansoh Pharmaceutical Group Co Ltd
• Jiangsu Hengrui Medicine Co Ltd
• Jiangsu T-mab BioPharma Co Ltd
• Keros Therapeutics Inc
• Kyoto Pharmaceutical Industries Ltd
• Lactocore Inc
• LBL Biotech Corp
• Lead Discovery Center GmbH
• LEXEO Therapeutics LLC
• Link Biologics Ltd
• Lupin Ltd
• Luye Pharma Group Ltd
• Mabxience Holding SL
• Max Biopharma Inc
• Merck & Co Inc
• Mesentech Inc
• Mezomax Inc
• Nano Intelligent Biomedical Engineering Corp
• Nanomedic Inc
• NeuClone Pty Ltd
• NovMetaPharma Co Ltd
• Omeros Corp
• Oncosimis Biotech Pvt Ltd
• Ortho Regenics Pvt Ltd
• OssiFi Inc
• Paras Biopharmaceuticals Finland Oy
• PhytoHealth Corp
• Prestige BioPharma Ltd
• PRG S&Tech Inc
• Qilu Pharmaceutical Co Ltd
• Radius Health Inc
• Rani Therapeutics LLC
• Regenerative Arthritis & Bone Medicine Inc
• Reliance Life Sciences Pvt Ltd
• Reven Holdings Inc
• Ribomic Inc
• Samsung Bioepis Co Ltd
• Sandoz International GmbH
• Shaanxi Micot Technology Co Ltd
• Shandong New Time Pharmaceutical Co Ltd
• Shanghai Celgen Bio-Pharmaceutical Co Ltd
• Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
• Shanghai Henlius Biotech Inc
• Shanghai Junshi Bioscience Co Ltd
• Shanghai Mab Venture Biopharm Co Ltd
• Shenzhen Salubris Pharmaceuticals Co Ltd
• Shin Poong Pharm Co Ltd
• Stelis Biopharma Ltd
• Surrozen Inc
• Suzhou Stainwei Biotech Inc
• Taithera Inc
• Takeda Pharmaceutical Co Ltd
• Tempest Therapeutics Inc
• Teva Pharmaceutical Industries Ltd
• The National Institute for Biotechnology in the Negev Ltd
• The United Laboratories International Holdings Ltd
• Tritech Biopharmaceuticals Co Ltd
• TSH Biopharm Corporation Ltd
• Uni-Bio Science Group Ltd
• Vibe Pharmaceuticals LLC
• Vidasym Inc
• Viking Therapeutics Inc
• Wuxi Hebang Biotechnology Co Ltd
• Yooyoung Pharm Co Ltd
• Zosano Pharma Corp
• Zydus Lifesciences Ltd